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Background: The World Health Organization now recommends parasitological confirmation for malaria case
management. Rapid diagnostic tests (RDTs) for malaria are an accurate and simple diagnostic to confirm parasite
presence in blood. However, where they have been deployed, adherence to RDT results has been poor, especially
when the test result is negative. Few studies have examined adherence to RDTs distributed or purchased through
the private sector.
Methods: The Rapid Examination of Malaria and Evaluation of Diagnostic Information (REMEDI) study assessed the
acceptability of and adherence to RDT results for patients seeking care from private sector drug retailers in two
cities in Oyo State in south-west Nigeria. In total, 465 adult participants were enrolled upon exit from a participating
drug shop having purchased anti-malaria drugs for themselves. Participants were given a free RDT and the appropriate
treatment advice based on their RDT result. Short Message Service (SMS) text messages reiterating the treatment
advice were sent to a randomly selected half of the participants one day after being tested. Participants were
contacted via phone four days after the RDT was conducted to assess adherence to the RDT information and
treatment advice.
Results: Adherence to RDT results was 14.3 percentage points (P-val <0.001) higher in the treatment group who
were sent the SMS. The higher adherence in the treatment group was robust to several specification tests and the
estimated difference in adherence ranged from 9.7 to 16.1 percentage points. Further, the higher adherence to the
treatment advice was specific to the treatment advice for anti-malarial drugs and not other drugs purchased to
treat malaria symptoms in the RDT-negative participants who bought both anti-malarial and symptom drugs.
There was no difference in adherence for the RDT-positive participants who were sent the SMS.
Conclusions: SMS text messages substantially increased adherence to RDT results for patients seeking care for
malaria from privately owned drug retailers in Nigeria and may be a simple and cost-effective means for boosting
adherence to RDT results if and when RDTs are introduced as a commercial retail product.
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Although recent World Health Organization guidelines
for malaria management in endemic countries recom-
mend that treatment should be reserved for confirmed
malaria cases [1], presumptive diagnosis of malaria and
subsequent over-administration of anti-malarial drugs
remain the norm [2]. With the recent improvements in
the accuracy of rapid diagnostic tests (RDTs) for mal-
aria, there is an opportunity to improve the quality of
diagnosis and treatment. RDTs are antigen-based tests
that detect parasite-specific antibodies or antigens in a
drop of blood within 15 minutes. RDTs are easy to use
and have similar or superior specificity and sensitivity
to microscopy, the previous gold-standard diagnostic
[3,4]. The relative simplicity of RDTs enables their use by
those with minimal medical training [5] and their low cost
make them a potentially cost-effective intervention for
malaria management in low resources settings [6].
There has been a rapid increase in the availability of
RDTs throughout many sub-Saharan African countries
[7]. However, patient adherence to test results has been
poor, especially when the test results are negative [8,9].
When RDT-negative patients disregard RDT results, the
potential of RDTs to increase the cost-effectiveness of
malaria treatment is undermined because 1) savings
from unnecessary treatments are not realized, and 2)
over-administration of first-line anti-malarial drugs may
fuel parasite resistance and/or diminished efficacy over
time.
Strategies to improve adherence to RDTs have been
attempted in countries where the public sector has imple-
mented strict case management guidelines. In Senegal,
where artemisinin-based combination therapy (ACT) is
only given with a positive RDT result, the number of ACT
prescriptions now matches malaria prevalence [10]. How-
ever, such strategies are unlikely to be successful in coun-
tries where the majority of health services are provided
through the private sector, such as in Nigeria [11]. In these
countries, alternative strategies to reinforce treatment ad-
herence to test results may be needed in lieu of strong
regulatory control.
A series of recent studies have shown that reminders
sent via short message service (SMS) can ‘nudge’ people
to increase adherence to a variety of health related behav-
iours, including applying sunscreen [12], remembering to
take diabetes drugs [13], following HIV antiretroviral ther-
apy treatment regimens [14], and adhering to asthma
treatment [15]. For RDT use in malaria case management,
a ‘nudge’ may help people adhere to RDT results among
those who are hesitant to follow through because of insuf-
ficient previous experience. Reinforcement of the appro-
priate health behaviour indicated by the RDT may be
particularly valuable when the test result conflicts with
prior expectations of having malaria. While there is someconsensus that SMS-based reminder interventions may be
well-suited to developing countries [16,17], there has not
been any work to date to examine the extent to which
SMS messages can be leveraged to increase adherence to
RDT results.
This study evaluates a pilot SMS-based intervention
included in the Rapid Examination of Malaria and Evalu-
ation of Diagnostic Information (REMEDI) study con-
ducted in Oyo State in south-west Nigeria. The goal of the
REMEDI study was to evaluate the acceptability of RDTs
among people seeking malaria drugs from private sector
drug retailers (detailed below in study design section). As
a part of the study, half of the enrolled participants were
randomly assigned to receive an SMS message, which 1)
reiterated the participant’s RDT result and corresponding
treatment advice, and 2) provided a platform whereby




The REMEDI SMS pilot was a double-blinded, parallel-
group study conducted in Oyo state in south-west Nigeria,
in and around the cities of Ibadan and Ogbomosho.
Ibadan is a large urban center, while Ogbomosho is mainly
peri-urban. The main goal of the REMEDI study was to
examine the acceptability of RDTs among customers of
private sector retail outlets. Privately owned pharmacies
and proprietary and patent medicine vendors (PPMVs)
were initially randomly selected from the enumerated sites
within four local government areas and enrolled into the
study. Two weeks after the beginning of the study, the site
selection was modified to exclude small drug retailers
whose main business was not medicinal sales; these
PPMVs were replaced with other PPMVs in the adjacent
local government areas.
At each retail site, adult customers exiting the shop
were approached, screened for eligibility, and asked to
complete a short survey. In brief, the protocol entailed
1) enrolling non-pregnant adults outside of a pharmacy/
drug shop who stated and demonstrated that they had
just purchased malaria treatment for him/herself; 2) of-
fering and conducting an RDT performed by a trained
nurse; 3) taking a detailed survey and inventory of drugs
purchased; 4) discussing the test result with the patient;
and 5) providing appropriate treatment advice based on
the test result at the end of the survey. If the partici-
pant’s RDT was positive, the patient was told that the
positive result indicates the presence of malaria and was
instructed to take a course of ACT, that was provided
for free. If the participant’s RDT test was negative, the
patient was told that the negative result indicates the ab-
sence of malaria and that anti-malarial drugs would not
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The nurse informed participants that they could still
take other medications they purchased for other condi-
tions or to treat symptoms.
Regardless of the test result, all participants were re-
ferred to local clinics and hospitals where they could
seek care if their condition was not malaria or if their ill-
ness became worse. All participants were also given an
informational card that outlined treatment steps based
on their test result. Lastly, participants were asked for
their cell phone contact information and told to expect a
short 5–10 minute phone call in four days to check on
the status of their illness, during which they would be
compensated with 100 Naira (US$0.63) in phone credits
for taking the call.
In the follow-up phone survey four days after the ini-
tial encounter, participants were asked which of the pur-
chased drugs they had used. Responses to this question
were used as a measure of adherence to the RDT infor-
mation and treatment advice.
SMS intervention protocol and complications
SMS messages were sent to randomly selected participants
one day after the initial encounter. The same message
was sent to each participant once in English and once in
Yoruba (the dominant local ethnic group). The content
of the message repeated the advice given by the nurse
the previous day at the time of testing and included a
final line stating that patient could reply to the nurse via
text if they need additional information.
Two text messages were sent based on the participant’s
RDT, one in English and a second in Yoruba. RDT posi-
tive participants were sent the following message in
English, “Yesterday, you tested POSITIVE for malaria.
Take LUMARTEM. If questions, please reply or TEXT.
A nurse will call you soon.” A second message was sent
separately in Yoruba, “Lanaa, iwadii fi han pe E NI IBA.
E maa lo ACT yin bo se ye. Te e ba ni ibeere, e fesi ater-
anse yii, noosi wa yoo si daa yin lohun logan.” RDT
negative participants were sent the following message in
English, “Yesterday, you tested NEGATIVE for malaria.
Malaria drugs NOT needed. If questions, please reply or
TEXT. A nurse will call you soon.” Again a second mes-
sage was sent separately in Yoruba, “Lanaa, iwadii wa
han pe E O NI IBA. Eyi fi han pe e o nilo oogun iba. Te
e ba ni ibeere, e fesi ateranse yii, noosi wa yoo si daa yin
lohun logan.”
To ensure that none of the survey staff would know
who were chosen to receive the SMS, the study manager,
who did not have any interaction with participants,
randomly assigned surveys into the treatment group
after the surveys were returned to the study office each
day. The protocol for treatment assignment entailedassigning every other survey to the SMS treatment
group on the day of the baseline survey. However, due
to disruptions in electricity and communications chan-
nels with the study site in Ogbomosho, surveys col-
lected in Ogbomosho were not returned to the study
office in time for assignment to treatment/control group
the same day. On days when disruptions prevented the
study manager from following assignment protocol,
treatment assignment was slightly altered. Additional
surveys from Ibadan were randomly assigned to the
treatment group to compensate for fewer treatment as-
signments from Ogbomosho. During these periods of
delay in transmissions from Ogbomosho, one additional
Ibadan-based survey was selected to receive an SMS for
every two surveys collected in Ogbomosho. These “off-
protocol” treatment assignments are taken into account
in the statistical analyses of the data.
Participants
Of 465 adults enrolled adults, all of whom completed
the baseline survey; 32 participants were not reached for
follow-up. An additional eight surveys had duplicated
survey numbers, so these observations were dropped, as
it was impossible to tell which entry was correct. With
these exclusions, 425 participants remain who were
reached in the follow-up phone survey. Only 419 obser-
vations are analysed because four surveys did not have
drug information data, one was missing site information
and one was ineligible upon further inspection. In total,
213 participants were sent the SMS reminder one day
after their RDT was conducted at the phone number
they provided. Figure 1 presents a flow chart outlining
the surveys included for analysis.
Statistical analyses
Descriptive analyses present sample characteristics, the
randomization of participants, and the distribution of
variables between treatment and control groups. The
main analysis examines whether participants adhered to
the recommended treatment course based on their RDT
result. Specifically, participants are considered to have
“followed treatment advice” if (1) they were RDT-
negative and did not take any of the anti-malarial medi-
cations purchased or (2) if they were RDT-positive and
took ACT. This binary outcome is predicted using lo-
gistic regression to compare the SMS treatment group
to those who were not sent an SMS. Standard errors
are clustered by retail site where the surveys were
conducted.
The primary analysis estimates the “intent to treat”
effect. Mean differences across treatment and control
groups, odds ratios (risk ratio), and risk differences
!!
Surveys conducted (n=465) 
Excluded 8 surveys 
Survey numbers coded wrong 
Analysed  (n=213)
2 excluded from analysis (no treatment data)
13 Lost to follow-up (n=215)
No phone survey
Allocated to intervention (n=228)
19 Lost to follow-up (n=210)
No phone survey
Allocated to control (n=229)
Analysed  (n=206)
excluded from analysis (no treatment data)








Conducted in Ibadan 
(n=177)










Figure 1 Data exclusion flow chart.
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are employed:
Model 1
Log Adhere= 1−Adhereð Þð Þ ¼ aþ b SMSð Þ þ e
Model 2
Log Adhere= 1−Adhereð Þð Þ ¼ aþ b SMSð Þ
þ g SMS  Ibadanð Þ
þ π Ibadanð Þ þ e
Model 3
Log Adhere= 1−Adhereð Þð Þ ¼ aþ b SMSð Þ
þ g SMS  Ibadanð Þ
þ π Ibadanð Þ
þ h SMS Off−protocolð Þ
þ μ Off−protocolð Þ þ e
Model 4
Log Adhere= 1−Adhereð Þð Þ ¼ aþ b SMSð Þ
þ g SMS  Ibadanð Þ
þ π Ibadanð Þ
þ h SMS Off−protocolð Þ
þ μ Off−protocolð Þ
þ ρ Unbalance variablesð Þ
þ e
Model 1 compares the difference in mean adherence
between the treatment and the control group. To account
for potential differences in the effectiveness of the SMS
intervention between Ogbomosho and Ibadan, Model 2adds an indicator variable for each city and an interaction
term between the treatment and the city in which partici-
pants were surveyed. In Model 3, an interaction term for
SMS treatment assignment on off-protocol days and an
indicator for off-protocol assignment are added to exam-
ine potential differences due to disruptions experienced in
Ogbomosho. Lastly, Model 4 adds controls for observable
sociodemographic variables that are unbalanced across
groups to further control for potential differences between
treatment and control individuals.
Two additional outcomes are analysed. A secondary
analysis examines the effect of the SMS intervention on
those who report actually seeing the SMS, or the “treat-
ment on the treated effect.” This analysis excludes 39
participants who were sent an SMS, but who reported
that they did not see it. Lastly, to determine whether the
SMS influenced only anti-malarial drug adherence ver-
sus other non-malarial drugs purchased, the same re-
gression analyses are used to predict the likelihood of
taking malaria and non-malarial drugs among a subset
of RDT-negative participants who bought both types of
drugs. While the SMS message only provided advice on
the appropriate use of anti-malarial drugs, it is unclear
whether this advice also affected participants’ usage of
non-malarial drugs that are beneficial for treatment of
symptoms. This analysis captures the specificity of the
response to the content of the SMS message by examin-
ing the relationship between receiving the SMS message
and usage of both anti-malarial and symptom drugs. For
these additional outcomes group differences, odds ratios
(risk ratio), and risk differences (marginal effects) are






N Mean or % N Mean or %
Sites
PPMV& 81 38.0% 109 52.9%
Ogbomosho& 36 16.9% 79 38.3%
Demographics
Male 109 51.2% 102 50.0%
Age 40.7 37.3
Married 157 73.7% 131 63.9%
Literacy status
Can not read or write*& 209 98.1% 189 91.7%
Education level
Less than primary 14 6.6% 16 7.8%
Completed primary 27 12.7% 29 14.1%
Completed secondary 88 41.5% 76 37.1%
More than secondary 83 39.2% 84 41.0%
Assets/infrastructure
Electricity 204 95.8% 196 95.1%
Radio 199 93.4% 189 91.7%
TV 193 90.6% 188 91.3%
Refrigerator 144 67.6% 129 62.6%
Cable TV& 114 53.8% 90 43.7%
Generator 152 71.4% 144 70.6%
AC 36 16.9% 29 14.1%
Computer 75 35.4% 78 38.0%
Electric iron 195 91.5% 179 87.3%
Fan 194 91.1% 189 92.2%
Motorcycle/scooter& 36 16.9% 58 28.3%
Car 102 47.9% 91 44.2%
Bank account*& 189 88.7% 154 74.8%
Flush toilet in house& 171 80.3% 144 69.9%
Kerosene to cook 116 54.5% 126 61.2%
Concrete floors 139 65.9% 126 62.1%
RDT prevalence
RDT positive& 12 5.6% 4 1.9%
&Variables are statistically different across treatment and control groups.
*Variables remain statistically different across treatment and control groups
even within city (Ibadan/Ogbomosho0.)
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Ethical considerations
The University of California, San Francisco’s institutional
review board and Nigeria’s National Health Research
Ethics Committee approved the REMEDI study protocol.
Surveyors obtained written consent from all study
participants.
Results
Table 1 presents sample characteristics for participants
across treatment and control groups. The intervention
and control groups are significantly different in terms of
literacy and having cable TV, a motorcycle, a bank ac-
count, a flush toilet, and RDT-positive prevalence. Once
the city in which the survey was conducted is controlled
for, only having a bank account (88.7% vs. 74.8%) and
not being able to read or write (98.1% vs. 91.7%) remain
significantly different. Hence, these unbalanced vari-
ables are controlled for in subsequent regression model
specifications.
Table 2 shows estimates of the intent to treat analysis.
A simple comparison of means shows that 79.8% of par-
ticipants who were sent an SMS adhered to the treat-
ment advice compared to only 65.5% who were not sent
an SMS. This translates into a 14.3 percentage point
(95% CI: 6.68-21.9 percentage points) increase in adher-
ence, with an odds (risk) ratio of 2.08 (95% CI: 1.44-
3.01). When controlling for and allowing for different
treatment effect by location in row 2, the estimate re-
duces to a 10.1 percentage point difference (95% CI:
3.66-16.6 percentage points) between the treatment and
control groups, with an odds (risk) ratio of 1.70 (95% CI:
1.20-2.42). Further accounting for the influence of
assigning treatment to SMS reminders off-protocol in
row 3 and controlling for unbalanced baseline asset vari-
ables in row 4 returns treatment effect estimates similar
to the unadjusted estimates in row 1.
In Table 3, estimates of the treatment effect on the
treated excluding 39 participants who reported that they
did not see the SMS are presented. Adherence to the
treatment advice in the SMS group increases to 81.6%.
Unconditional means in row 1 show that adherence was
higher in the SMS group by 16.1 percentage points (95%
CI: 8.89-23.2 percentage points). The SMS group had a
higher likelihood of adhering to treatment advise with
an odds (risk) ratio of 2.33 (95% CI: 1.62-3.36). In speci-
fications where differences by city and/or issues of off-
protocol assignment were accounted for, the estimated
treatment effect on the treated ranges from 11.3 per-
centage points (95% CI: 3.76-18.9 percentage points) to
15.5 percentage points (95% CI: 7.86- 23.2 percentage
points).In Table 4, only the subset of RDT-negative partici-
pants who bought both symptom drugs and anti-
malarial drugs are analysed. Of these 240 RDT-negative
participants, 23.1% who were sent an SMS took their
purchased anti-malarial drugs compared to 41.5% who
were not sent an SMS. In other words, significantly
fewer participants—18.4 percentage points (95% CI: −30.1
Table 2 Logistic regression results for the intent to treat effect of SMS reminders on adherence to treatment advice
Primary outcome Percentage (N) SMS SMS
SMS sent (213) SMS not sent (206) SMS risk ratio (95% CI) Risk difference (95% CI)
1 Followed treatment advice 79.8% (170) 65.5% (135) 2.08 (1.44–3.01) 14.3% (6.68%–21.9%)
2 Followed treatment advice* 1.70 (1.20–2.42) 10.1% (3.66%–16.6%)
3 Followed treatment advice** 2.19 (1.50–3.18) 14.8% (8.14%–21.4%)
4 Followed treatment advice*** 2.13 (1.45–3.12) 14.2% (7.33%–21.1%)
N = 419.
*Controls for city survey was conducted (Ibadan/Ogbomosho) and treatment*city survey was conducted (Model 2).
**Controls for city survey was conducted (Ibadan/Ogbomosho), treatment*city survey was conducted, whether assignment to the treatment/control group was
made off-protocol, and treatment* whether survey assignment to the treatment/control group was made off-protocol (Model 3).
***Controls for city survey was conducted (Ibadan/Ogbomosho), treatment*city survey was conducted, whether assignment to the treatment/control group was
made off-protocol, and treatment* whether survey assignment to the treatment/control group was made off-protocol, an indicator variable for surveys conducted
at PPMVs, an indicator variable for participant who had a bank account, and an indicator variable for participant could not read or write (Model 4).
Standard errors are clustered by retail site.
Modrek et al. Malaria Journal 2014, 13:69 Page 6 of 8
http://www.malariajournal.com/content/13/1/69to −6.7 percentage points)—who were sent an SMS took
the unnecessary anti-malarial drugs. For comparison,
73.5% of participants who were sent an SMS took their
symptomatic drugs compared to 80.5% were not sent an
SMS, a difference of 7 percentage points that was not sta-
tistically significant.
Table 5 presents the patterns of anti-malarial drug use
for RDT-positive participants. There were only 16 RDT-
positive participants so regression analyses are not con-
ducted. Of these 16 RDT-positive participants, 75% took
anti-malarial drugs regardless of whether they were sent
an SMS or not. All RDT-positive participants who bought
symptom drugs reported that they took these drugs.
Discussion
This study demonstrated that a simple SMS text message
substantially increased adherence to RDT results. Com-
pared to those who were not sent a reminder message, the
probability of adhering to the correct malaria treatment
advice increases by 10–15 percentage points among those
who were sent the reminder. Previous estimates of the
magnitude in the effect size of SMS interventions to in-
crease adherence to drug treatments range from 8-17%Table 3 Logistic regression estimates of the treatment on tre
advice
Primary outcome Percentage (N)
Received SMS (n = 174) SMS not s
1 Followed treatment advice 81.6% (142) 65.5
2 Followed treatment advice*
3 Followed treatment advice**
4 Followed treatment advice***
Exclude 39 observations who were sent a text message but who reported not seein
*Controls for city survey was conducted (Ibadan/Ogbomosho) and treatment* city s
**Controls for city survey was conducted (Ibadan/Ogbomosho), treatment* city surv
made off-protocol, and treatment* whether survey assignment to the treatment/co
***Controls for city survey was conducted (Ibadan/Ogbomosho), treatment* city sur
made off-protocol, and treatment* whether survey assignment to the treatment/co
at PPMVs, an indicator variable for participant who had a bank account, and an ind
Standard errors are clustered by retail site.[12-14,18] —the estimates in this study are very much in
line with those studies. Together, these studies suggest
that for many health-related behaviours, individuals may
benefit from additional reinforcement to help them to fol-
low through with intended or prescribed behaviours.
Unlike previous SMS intervention studies in which the
message often persuaded the participant to do some-
thing that the individual already stated that s/he wanted
to do (e.g. use sunscreen, take medication, or save
money), in this study the message reinforces a previously
given medical advice, which likely contradicted the
planned behaviour of the participants. Indeed, the vast
majority of the participants tested were found to have
negative results (96%). These individuals, having just
purchased treatment medicines, were essentially asked
to change behaviour and not do something they usually
would do—take an anti-malarial drug—to treat a sus-
pected episode of malaria. This suggests that reminder
messages can help individuals break from their default be-
haviours in addition to helping them follow through with
intended behaviours.
To further understand how the SMS intervention may
have influenced participants’ choices, participants in theated effect of SMS reminders on adherence to treatment
SMS SMS
ent (n = 206) SMS risk ratio (95% CI) Risk difference (95% CI)
% (135) 2.33 (1.62–3.36) 16.1% (8.89%–23.2%)
1.84 (1.19–2.85) 11.3% (3.76%–18.9%)
2.34 (1.46–3.74) 15.5% (7.86%–23.2%)
1.68 (1.08–2.61) 9.68% (1.84%–17.5%)
g the text message in the follow-up survey, N = 380.
urvey was conducted (Model 2).
ey was conducted, whether assignment to the treatment/control group was
ntrol group was made off-protocol (Model 3).
vey was conducted, whether assignment to the treatment/control group was
ntrol group was made off-protocol, an indicator variable for surveys conducted
icator variable for participant could not read or write (Model 4).
Table 4 Logistic regression results for the effect of SMS reminders on malaria and non-malaria drug-taking
Medications taken Percentage (N) SMS SMS
SMS sent (n = 117) SMS not sent (n = 123) SMS risk ratio (95% CI) Risk difference (95% CI)
1 Took anti-malarial 23.1% (27) 41.5% (51) 0.42 (0.25–0.72) −18.4% (−30.1% to −6.7%)
2 Took anti-malarial** 0.37 (0.20–0.69) −20.6% (−32.5% to −8.8%)
3 Took symptom drug 73.5% (86) 80.5% (99) 0.67 (0.37–1.20) −7.0% (−17.3% to 3.31%)
4 Took symptom drug** 0.89 (0.42–1.90) −2.1% (−15.2% to 11.1%)
Sample includes RDT negative participants who bought both an antimalarial drug as well as drugs to treat their symptoms, N = 240.
**Controls for city survey was conducted (Ibadan/Ogbomosho), treatment* city survey was conducted, whether assignment to the treatment/control group was
made off-protocol, and treatment* whether survey assignment to the treatment/control group was made off-protocol (Model 3).
Standard errors are clustered by retail site.
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the SMS message they found helpful. The majority of re-
spondents (52%) said that the SMS reminded them of
their test result, while another 30% said that it reminded
them of the correct treatment course. Only about 10%
mentioned the usefulness of having a link to an advice
nurse and only 10 participants actually contacted the ad-
vice nurse for consultation regarding unresolved febrile
symptoms or to confirm that they should not take the
anti-malarial medication. Hence, it appears that the
reinforcement of the medical advice reiterated by the
SMS was the most helpful to participants in choosing
which drugs to take for their condition.
Given the ubiquity of cell phones throughout Nigeria
and the relatively low cost of sending an SMS compared
to the cost of anti-malaria drugs, the SMS intervention
is cost-effective from a societal point of view. The aver-
age cost of the anti-malaria treatment course purchased
within the study sample was 350 Naira (US$2.50). This
cost reflects only the retail price of treatments and does
not include the large-scale international subsidy for
ACT, which is about $4.00 a course. Based on the results
of this study, a similar SMS intervention would save
$0.25 per episode in direct treatment costs alone. If the
proportion of participants who bought ACT and inter-
national subsidy were taken into consideration, then the
cost savings would average $0.43 per episode. Rough es-
timates of the cost of sending an SMS manually is about
10 cents including labour and service costs, suggesting
that the SMS intervention is a cost-saving one. If the
SMS messages were automated the cost be would even
lower.
This study provides further evidence that reminding or
nudging people can alter health-related behaviours.
However, these results should be interpreted in light of
several caveats. For various reasons, randomization wasTable 5 Medication use for RDT positive participants
Medication use Percentage (N)
SMS sent (n = 12) SMS not sent (n = 4)
Took anti-malarial 75% (9) 75% (3)
N = 16.not perfectly balanced, although application of regres-
sion controls helped to adjust for these factors. Because
the pilot study was conducted in primarily urban areas,
this sample is unlikely to be representative of the state
or of the country. Results reflect a wealthier and more
educated population and health behaviours may differ,
including responses to SMS messages, for poorer popu-
lations located in rural areas. An expanded version of
this study is currently underway to assess the extent to
which SMSs increase RDT adherence in other states, in
areas with higher entomological inoculation rates, and in
more representative populations. Further, because adher-
ence to treatment advice is a self-reported measure,
some reporting bias may be present if the SMS message
also prompted individuals to self-report “better” out-
comes. To the extent that the SMS increased reporting
bias, the intervention effect size could be over-
estimated. However, because results for malaria drugs
and non-malaria drugs showed differential drug-taking
behaviour, such self-reporting bias may be minimal. Fi-
nally, the SMS contained the exact same information
that was provided by the advice nurse. For this reason,
the SMS may have served as a general reminder of the
testing experience, and in the present study the effect of
a general reminder from the effect of the precise mes-
sage contained within the SMS could not be differenti-
ated. Future interventions would need to test different
wording of the message to see which word choices in-
crease adherence the most.
Currently, innovations in integrating RDTs into malaria
case management in the private sector are well underway.
Though this pilot study was limited to customers seeking
care for malaria in the private sector healthcare market in
Nigeria, RDT roll out is likely to expand in all sectors, and
the results of this pilot study could have broader implica-
tions. The results suggest that SMS may be a tool to in-
crease adherence to RDT results and could be used by
many different health care practitioners (such as commu-
nity health workers or hospital nurses) to support patients
in following appropriate treatment advice. Coupling the
RDT roll out with reinforcement messaging could help
bring ACT use in line with actual malaria cases.
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